Vaccines against tuberculosis: A review.

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases

Background:

• Tuberculosis (TB) remains a significant global health burden, necessitating improved preventative strategies.
• The Bacillus Calmette-Guérin (BCG) vaccine offers protection against severe childhood TB but lacks efficacy in pulmonary TB.
• There is a critical unmet need for a more effective TB vaccine.

Purpose of the Study:

• To highlight the limitations of the current BCG vaccine for tuberculosis.
• To emphasize the ongoing need for novel and effective TB vaccine development.
• To underscore the importance of rigorous safety and efficacy evaluations for new TB vaccine candidates.

Main Methods:

• Literature review on TB vaccine efficacy and development.
• Analysis of the immunological response to BCG vaccination.
• Examination of current TB vaccine candidates in clinical trials.

Main Results:

• BCG vaccine demonstrates limited efficacy against pulmonary tuberculosis in adults.
• Several new TB vaccine candidates are progressing through clinical trials.
• Data on the long-term safety and efficacy of new candidates is still pending.

Conclusions:

• Development of a broadly protective and effective TB vaccine is a high priority.
• New TB vaccine candidates require thorough assessment before integration into national immunization programs.
• Continued research is essential to combat the global impact of tuberculosis.